Financial Summary Third Quarter Consolidated 2026 October Term

Overview of performance

In the cumulative third quarter period, net sales increased year on year, but due to a high hardware composition ratio and increased procurement costs from rising semiconductor prices, operating income, ordinary income, and net income fell below the prior year. Demand for the medical information systems market remains solid, and the growth foundation is maintained with additional orders for digital transformation-related solutions. The full-year forecast remains as previously projected. There is a note regarding treasury stock movements.

Outlook and capital position

The consolidated full-year earnings forecast is maintained at the time of disclosure: net sales of 44,338 million yen, operating income of 8,795 million yen, ordinary income of 8,875 million yen, net income attributable to owners of the parent of 5,982 million yen, and earnings per share of 1,142.94 yen. Assets declined due to reductions in cash and deposits and accounts receivable, with movements in the disposition/acquisition of treasury stock noted; the ending balance of treasury stock is unknown.